Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 9/20 | 0.74 |
| ▸ | PTGS1 | P23219 | 8/20 | 0.67 |
| ▸ | CA1 | P00915 | 6/20 | 0.64 |
| ▸ | CA2 | P00918 | 6/20 | 0.64 |
| ▸ | CA4 | P22748 | 6/20 | 0.64 |
| ▸ | CA9 | Q16790 | 6/20 | 0.64 |
| ▸ | CHRNA7 | P36544 | 4/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6341812 | 0.92 | PTGS2 (0.71) | PTGS2PTGS1CA1CA2CA4 | |
| SCHEMBL28248642 | 0.90 | PTGS2 (0.58) | PTGS2PTGS1CA1CA2CA4 | |
| SCHEMBL6349532 | 0.90 | PTGS2 (0.69) | PTGS2PTGS1CA1CA2CA4 | |
| SCHEMBL6351372 | 0.89 | PTGS2 (0.67) | PTGS2PTGS1CA1CA2CA4 | |
| SCHEMBL6353455 | 0.89 | PTGS2 (0.70) | PTGS2PTGS1CA1CA2CA4 | |
| SCHEMBL6341478 | 0.85 | PTGS2 (0.79) | PTGS2PTGS1CA1CA2CA4 | |
| SCHEMBL6339325 | 0.85 | PTGS2 (1.00) | PTGS2PTGS1CA1CA2CA4 | |
| SCHEMBL8120953 | 0.84 | PTGS2 (0.72) | PTGS2PTGS1CA1CA2CA4 | |
| SCHEMBL3867425 | 0.83 | PTGS2 (0.63) | PTGS2PTGS1CA1CA2CA4 | |
| SCHEMBL6350079 | 0.83 | PTGS2 (0.79) | PTGS2PTGS1CA1CA2CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5753688-A | ANTIINFLAMMATORY | TALLEY JOHN J (US) | 1998-05-19 | — | — | US | disclosed |
| US-5563165-A | PROSTAGLANDIN INHIBITOR; FDA ORANGE BOOK LISTED PATENT FOR CELEBREX | G. D. SEARL & CO. (US) | 1996-10-08 | — | — | US | disclosed |
| US-5521207-A | Substituted pyrazolyl benzenesulfonamide for the treatment of inflammation | G.D. SEARLE & CO. (US) | 1996-05-28 | — | — | US | disclosed |
| US-5516907-A | ANTIINFLAMMATORY AGENTS | G.D. SEARLE & CO. (US) | 1996-05-14 | — | — | US | disclosed |
| US-5510496-A | ANTIINFLAMMATORY AGENTS | G.D. SEARLE & CO. (US) | 1996-04-23 | — | — | US | disclosed |
| US-5508426-A | ANTIARTHRITIC AGENT | G. D. SEARLE & CO. (US) | 1996-04-16 | — | — | US | disclosed |
| US-5504215-A | Substituted pyrazolyl benzenesulfonamide compounds for the treatment of inflammation | G. D. SEARLE & CO. (US) | 1996-04-02 | — | — | US | disclosed |
| US-5466823-A | Antiinflammatory agents; FDA Orange book listed patent for Celebrex | G.D. SEARLE & CO. (US) | 1995-11-14 | — | — | US | disclosed |